3-iodobenzylguanidine has been researched along with Death, Sudden, Cardiac in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 11 (26.83) | 29.6817 |
| 2010's | 22 (53.66) | 24.3611 |
| 2020's | 6 (14.63) | 2.80 |
| Authors | Studies |
|---|---|
| Bardai, A; Blom, MT; Karemaker, JM; Tan, HL; Verberne, HJ | 1 |
| Camargo, GC; de Almeida, SA; de Brito, ASX; de Holanda, MT; de Sousa, AS; Glavam, AP; Mendes, FSNS; Moll-Bernardes, RJ; Oliveira, RS; Pinheiro, MVT; Rosado-de-Castro, PH; Sangenis, LHC; Siqueira, FPR | 1 |
| Atabekov, TA; Batalov, RE; Mishkina, AI; Popov, SV; Sazonova, SI; Varlamova, JV; Zavadovsky, KV | 1 |
| Asai, K; Hoshika, Y; Ishikawa, M; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Ogano, M; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K | 1 |
| Brunotti, G; Conte, M; Corica, F; Cosma, L; De Angelis, C; De Feo, MS; De Vincentis, G; Di Rocco, A; Farcomeni, A; Frantellizzi, V; Lazri, J; Matto, A; Montebello, M; Pontico, M | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda, I; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Nakamura, J; Ozaki, T; Sato, Y; Seo, M; Tamaki, S; Yamada, T; Yamamoto, H | 1 |
| Travin, MI | 2 |
| Currie, G; Iqbal, B; Kiat, H | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda-Yorifuji, I; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Morita, T; Nakamura, J; Seo, M; Tamaki, S; Yamada, T | 1 |
| Carnagarin, R; Chan, JJS; Dwivedi, G; Ho, JK; Kiuchi, MG; Lugo-Gavidia, LM; Matthews, VB; Nolde, JM; Schlaich, MP; Villacorta, H | 1 |
| Martins da Silva, MI; Morão Moreira, AP; Vidigal Ferreira, MJ | 1 |
| Hashimoto, A; Nakata, T; Sugawara, H | 1 |
| Aggarwal, H; Ahmed, A; Chen, J; Hage, FG; Heo, J; Iskandrian, AE; Jacobson, AF; Patel, K | 1 |
| Al Badarin, FJ; Bateman, TM; Jacobson, AF; Kennedy, KF; Wimmer, AP | 1 |
| Amanullah, A; Gupta, S | 1 |
| Kasama, S; Kurabayashi, M; Toyama, T | 2 |
| Fukunami, M; Furukawa, Y; Hakui, H; Ishimi, M; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Ozaki, T; Sakata, Y; Sato, Y; Seo, M; Takahashi, S; Tamaki, S; Yamada, T | 1 |
| Borgquist, R; Singh, JP | 1 |
| Cerqueira, M; Farnum, C; Gold, M; Hendel, R; Narula, J; Shaw, L; Singh, J; Thomas, G; Wazni, O; Wolinsky, D | 1 |
| Doi, T; Hashimoto, A; Nakata, T; Yuda, S | 1 |
| Akutsu, Y; Asano, T; Gokan, T; Kaneko, K; Kawamura, M; Kobayashi, Y; Kodama, Y; Li, HL; Shinozuka, A; Tanno, K | 1 |
| Fukunami, M; Hori, M; Iwasaki, Y; Masuda, M; Morita, T; Okuda, K; Okuyama, Y; Sanada, S; Tamaki, S; Tsukamoto, Y; Yamada, T; Yasui, T | 1 |
| Heston, TF; Wahl, RL | 1 |
| Camici, PG; Carrió, I; Cowie, MR; Udelson, J; Yamazaki, J | 1 |
| Bax, JJ; Boersma, E; Boogers, MJ; Borleffs, CJ; Dibbets-Schneider, P; Henneman, MM; Schalij, MJ; Stokkel, MP; van Bommel, RJ; van der Wall, EE; van Ramshorst, J | 1 |
| Doi, T; Hashimoto, A; Nagahara, D; Nakata, T; Nishisato, K; Shimamoto, K; Shimoshige, S; Tsuchihashi, K; Yamamoto, H; Yuda, S | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Takayama, Y; Toyama, T | 1 |
| Fukunami, M; Furukawa, Y; Iwasaki, Y; Kawasaki, M; Komuro, I; Kuramoto, Y; Levy, WC; Morita, T; Okada, T; Okuyama, Y; Tamaki, S; Tanaka, K; Ueda, H; Yamada, T; Yasui, T | 1 |
| Kelesidis, I; Travin, MI | 1 |
| Canty, JM; Fallavollita, JA; Luisi, AJ; Suzuki, G | 1 |
| Druschky, A; Druschky, K; Hilz, MJ; Kuwert, T; Neundörfer, B; Pauli, E; Platsch, G; Stefan, H | 1 |
| Fukunami, M; Hori, M; Kioka, H; Masuda, M; Mine, T; Morita, T; Okuda, K; Tamaki, S; Tsukamoto, Y; Yamada, T | 1 |
| Hashimoto, A; Kyuma, M; Nagahara, D; Nakata, T; Noda, R; Shimamoto, K; Shimoshige, S; Tsuchihashi, K; Uno, K; Wakabayashi, T | 1 |
| Brewster, LM; Somsen, GA; van Eck-Smit, BL; Verberne, HJ | 1 |
| Chin, MC; Dae, MW; Lee, RJ; Moise, NS; Stillson, CA; Ursell, PC | 1 |
| Benvenuti, C; Castaigne, A; Dubois-Randé, JL; Duval, AM; Loisance, D; Merlet, P; Moyse, D; Pouillart, F; Syrota, A | 1 |
| Hashimoto, A; Nakata, T; Shimamoto, K; Travin, MI; Tsuchihashi, K; Wakabayashi, T; Yuda, S | 1 |
| Borggrefe, M; Breithardt, G; Eckardt, L; Haverkamp, W; Kies, P; Matheja, P; Schäfers, K; Schäfers, M; Schober, O; Schulze-Bahr, E; Wichter, T | 1 |
| Han, J; Kim, YH; Moon, DH | 1 |
9 review(s) available for 3-iodobenzylguanidine and Death, Sudden, Cardiac
| Article | Year |
|---|---|
The prognostic value of
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart Failure; Humans; Iodine Radioisotopes; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2022 |
New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Catecholamines; Death, Sudden, Cardiac; Disease Models, Animal; Ephedrine; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Sympathetic Nervous System; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Preoperative Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System | 2013 |
Cardiac metaiodobenzylguanidine imaging and heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Drug Monitoring; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment | 2013 |
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotoxicity; Death, Sudden, Cardiac; Ephedrine; Heart; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Prognosis; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2015 |
Usefulness of Cardiac Sympathetic Nerve Imaging Using (123)Iodine-Metaiodobenzylguanidine Scintigraphy for Predicting Sudden Cardiac Death in Patients With Heart Failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2016 |
Cardiac sympathetic imaging with mIBG in heart failure.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Tomography, Emission-Computed; Treatment Outcome | 2010 |
Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Humans; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2012 |
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Mediastinum; Meta-Analysis as Topic; Middle Aged; Myocardium; Prognosis; Radiopharmaceuticals; Survival Analysis | 2008 |
4 trial(s) available for 3-iodobenzylguanidine and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
Topics: 3-Iodobenzylguanidine; Aged; Benzhydryl Compounds; Blood Pressure; Body Weight; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography, Ambulatory; Female; Glucosides; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Parasympathetic Nervous System; Radionuclide Imaging; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Sympathetic Nervous System; Uric Acid | 2020 |
The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Cohort Studies; Death, Sudden, Cardiac; Female; Follow-Up Studies; Heart; Heart Failure, Systolic; Heart Ventricles; Humans; Male; Middle Aged; Neurons; Perfusion; Prognosis; Software; Sympathetic Nervous System; Technetium; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2014 |
Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Cardiac autonomic dysfunction in Brugada syndrome.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System; Autonomic Nervous System Diseases; Bundle-Branch Block; Death, Sudden, Cardiac; Electrocardiography; Female; Heart; Heart Ventricles; Humans; Iodine Radioisotopes; Male; Middle Aged; Neurons; Norepinephrine; Presynaptic Terminals; Radiopharmaceuticals; Syndrome; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon | 2002 |
28 other study(ies) available for 3-iodobenzylguanidine and Death, Sudden, Cardiac
| Article | Year |
|---|---|
An inherited sudden cardiac arrest syndrome may be based on primary myocardial and autonomic nervous system abnormalities.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System; Baroreflex; Death, Sudden, Cardiac; Female; Genetic Predisposition to Disease; Haplotypes; Heart Defects, Congenital; Heart Rate; Humans; Male; Middle Aged; Nervous System Malformations; Radionuclide Imaging; Syndrome; Ventricular Fibrillation | 2022 |
Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Autonomic Denervation; Chagas Cardiomyopathy; Chagas Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Fibrosis; Gadolinium; Humans; Myocardial Ischemia; Ventricular Premature Complexes | 2023 |
Prediction of appropriate ICD therapy in patients with ischemic heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Secondary Prevention; Tomography, Emission-Computed, Single-Photon | 2022 |
Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Assessing arrhythmic risk with
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart; Heart Failure; Humans; Iodine Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2019 |
Regional Cardiac Sympathetic Nervous System Evaluation Using 123I-mIBG SPECT in Patients with Heart Failure.
Topics: 3-Iodobenzylguanidine; Aged; Death, Sudden, Cardiac; Heart; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2018 |
Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardium; Prevalence; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk; Risk Assessment; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Prognosis; Radionuclide Imaging; Risk Assessment; Systole | 2014 |
Serial ¹²³I-metaiodobenzylguanidine imaging predicts the risk of sudden cardiac death in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Survival Rate | 2015 |
Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk; Ventricular Dysfunction, Left | 2015 |
An electrophysiologist perspective on risk stratification in heart failure: can better understanding of the condition of the cardiac sympathetic nervous system help?
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Autonomic Nervous System; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrophysiology; Heart; Heart Failure; Humans; Quality of Life; Risk Assessment; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed, Single-Photon | 2015 |
The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Consensus; Death, Sudden, Cardiac; Defibrillators, Implantable; Disease Management; Heart; Heart Failure; Heart-Assist Devices; Humans; Iodine Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2015 |
Multimodality molecular imaging in predicting ventricular arrhythmias and sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Echocardiography; Humans; Magnetic Resonance Angiography; Molecular Imaging; Multimodal Imaging; Tachycardia, Ventricular; Ventricular Function, Left | 2017 |
Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Output, Low; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2018 |
Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death.
Topics: 3-Iodobenzylguanidine; Adult; Death, Sudden, Cardiac; Female; Heart; Humans; Male; Prognosis; Radionuclide Imaging; Risk; Sympathetic Nervous System; Tachycardia, Ventricular; Time Factors | 2008 |
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with si
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; Heart Failure, Systolic; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2009 |
Clinical significance of iodine-123 metaiodobenzylguanidine cardiac imaging.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Heart Failure; Humans; Iodine Radioisotopes; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index | 2009 |
Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Death, Sudden, Cardiac; Defibrillators, Implantable; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Male; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sympathectomy; Sympathetic Nervous System; Tachycardia, Ventricular | 2010 |
Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Analysis of Variance; Arrhythmias, Cardiac; Coronary Circulation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Endpoint Determination; Female; Follow-Up Studies; Heart; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2010 |
Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Death, Sudden, Cardiac; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2011 |
Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Iodine Radioisotopes; Male; Middle Aged; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Severity of Illness Index; Survival Rate; Washington | 2011 |
Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium.
Topics: 3-Iodobenzylguanidine; Animals; Chronic Disease; Coronary Circulation; Coronary Stenosis; Death, Sudden, Cardiac; Disease Models, Animal; Heart; Iodine Radioisotopes; Myocardial Stunning; Norepinephrine; Swine; Sympathetic Nervous System; Tissue Distribution | 2002 |
Outcome of epilepsy surgery correlates with sympathetic modulation and neuroimaging of the heart.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Child, Preschool; Death, Sudden, Cardiac; Epilepsy, Temporal Lobe; Female; Heart; Heart Rate; Humans; Infant; Iodine Radioisotopes; Male; Myocardium; Neurosurgical Procedures; Norepinephrine; Sympathetic Fibers, Postganglionic; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vagus Nerve | 2003 |
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Disease-Free Survival; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Male; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2007 |
Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Dogs; Electrocardiography; Heart; Iodobenzenes; Myocardium; Radionuclide Imaging; Sympathetic Nervous System; Tachycardia, Ventricular | 1997 |
Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Dilated; Data Interpretation, Statistical; Death, Sudden, Cardiac; Echocardiography; Follow-Up Studies; Heart; Heart Transplantation; Hemodynamics; Humans; Iodine Radioisotopes; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Radiography, Thoracic; Radionuclide Ventriculography; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 1999 |
Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Case-Control Studies; Death, Sudden, Cardiac; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2001 |
Regional cardiac sympathetic denervation and systolic compression of a septal perforator branch in a sudden death survivor with hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Cardiomyopathies; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Death, Sudden, Cardiac; Echocardiography; Electrocardiography, Ambulatory; Follow-Up Studies; Heart Septum; Humans; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Male; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2002 |